2. November 2021
Dr. Falk Pharma and Zedira announce start of the phase 2b real-life study of ZED1227 for the treatment of Celiac Disease
Read more | Document
1. July 2021
Dr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease
Read more | Document
1. July 2021
Dr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie
Read more | Document
20. April 2021
Virtual Lecture Presentation during Digestive Disease Week (DDW) 2021
Read more | Document
22. January 2021
Clinical Validation of an Automated Fluorogenic FXIII Activity Assay
Read more

News

Blog

Events